TrialBMC medicine2024

Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for stages III-IV, unresectable ovarian cancer: a single-arm, open-label, phase Ib/II study.

Lina Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.